Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/234.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.)
Description: Subject matter involving a bacterium, a component of a bacterium, or a substance produced by a bacterium.










Sub-classes under this class:

Class Number Class Name Patents
424/246.1 Bacillus 141
424/253.1 Bordetella (e.g., bordetella bronchiseptica, etc.) 84
424/252.1 Brucella (e.g., brucella abortus, brucella canis, etc.) 34
424/263.1 Chlamydia (e.g., chlamydia trachomatis, etc.) 122
424/247.1 Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) 219
424/245.1 Corynebacterium (e.g., corynebacterium diphtheriae, etc.) 53
424/257.1 Escherichia (e.g., escherichia coli, etc.) 186
424/256.1 Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) 234
424/259.1 Klebsiella (e.g., klebsiella pneumoniae, etc.) 39
424/251.1 Moraxella (e.g., moraxella bovis, etc.) 70
424/248.1 Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) 420
424/264.1 Mycoplasma 66
424/249.1 Neisseria (e.g., neisseria gonorrhoeae, etc.) 137
424/255.1 Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) 108
424/242.1 Pilus, fimbria, or adhesin 95
424/260.1 Pseudomonas (e.g., pseudomonas aeruginosa, etc.) 120
424/258.1 Salmonella (e.g., salmonella typhimurium, etc.) 187
424/243.1 Staphylococcus (e.g., staphylococcus aureus, etc.) 178
424/244.1 Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) 418
424/236.1 Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) 537
424/235.1 Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) 127
424/262.1 Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) 46
424/261.1 Vibrio (e.g., vibrio cholera, etc.) 105


Patents under this class:

Patent Number Title Of Patent Date Issued
6881410 Treatment of E. faecium infection Apr. 19, 2005
6881411 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens Apr. 19, 2005
6881412 Modified live Flavobacterium columnare against columnaris disease in fish Apr. 19, 2005
6878377 Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system Apr. 12, 2005
6878816 Vmp-like sequences of pathogenic Borrelia Apr. 12, 2005
6875435 In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent Apr. 5, 2005
6872394 Non-toxic immune stimulating enterotoxin compositions Mar. 29, 2005
6872397 Method for treating neuromuscular disorders and conditions with botulinum toxin types A and B Mar. 29, 2005
6872542 Treatment or prophylaxis of diseases caused by pilus-forming bacteria Mar. 29, 2005
6872550 Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens Mar. 29, 2005
6872814 Chlamydia antigens and corresponding DNA fragments and uses thereof Mar. 29, 2005
6866855 Immunization of dairy cattle with GapC protein against Streptococcus infection Mar. 15, 2005
6867024 Ubiquinone composition and methods related thereto Mar. 15, 2005
6863893 Derivatives of choline binding proteins for vaccines Mar. 8, 2005
6863895 Mycobacterial sulfation pathway proteins and methods of use thereof Mar. 8, 2005
6861247 Salmonella secreted proteins and uses thereof Mar. 1, 2005
6861507 Screening of neisserial vaccine candidates and vaccines against pathogenic neisseria Mar. 1, 2005
6858209 Means for detecting bacteria of the taylorella equigenitalis species and their biological applications Feb. 22, 2005
6858211 Vaccines against Escherichia coli O157 infection Feb. 22, 2005
6858213 Mycobacterial sulfation pathway proteins and methods of use thereof Feb. 22, 2005
6858706 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof Feb. 22, 2005
6855321 Polyepitope carrier protein Feb. 15, 2005
6852322 Surface proteins of Leptospira Feb. 8, 2005
6846477 One dose vaccination with Mycoplasma hyopneumoniae Jan. 25, 2005
6844423 Compositions and methods for regulating bacterial pathogenesis Jan. 18, 2005
6841155 Immunization against and treatment for infection by H. pylori Jan. 11, 2005
6841156 Method for treating muscle spasm with botulinum toxin type B Jan. 11, 2005
6841159 Rapid lateral flow assay for determining exposure to Mycobacterium tuberculosis and other mycobacteria Jan. 11, 2005
6838089 Antigen delivery system and method of production Jan. 4, 2005
6838247 Test for lyme disease Jan. 4, 2005
6833134 Immunization of dairy cattle with GapC protein against Streptococcus infection Dec. 21, 2004
6827936 Synthetic peptide vaccines for dental caries Dec. 7, 2004
6824997 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies Nov. 30, 2004
6821520 Clostridial toxin therapy for Hashimoto's thyroiditis Nov. 23, 2004
6822075 Protein L and hybrid proteins thereof Nov. 23, 2004
6818221 Adjuvants and processes to induce a specific type of immune response Nov. 16, 2004
6818222 Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants Nov. 16, 2004
6818223 Abundant extracellular products and methods for their production and use Nov. 16, 2004
6814970 Methods and compositions including a 13 kD B. burgdorferi protein Nov. 9, 2004
6814971 Adjuvants for use in vaccines Nov. 9, 2004
6811787 Over-expressing homologous antigen vaccine and a method of making the same Nov. 2, 2004
6808711 Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines Oct. 26, 2004
6805868 Moraxella catarrhalis antigen, corresponding gene and uses thereof Oct. 19, 2004
6806069 Ubiquinone composition and methods related thereto Oct. 19, 2004
6806253 Immunodulatory complex and use thereof in helicobacter diseases Oct. 19, 2004
6803042 Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides Oct. 12, 2004
6803043 Basbo27 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses Oct. 12, 2004
6800734 Leptospira vaccine antigens for the prevention of Leptospirosis Oct. 5, 2004
6800791 Method for delivery of proteins to plant cells Oct. 5, 2004
6797276 Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response Sep. 28, 2004











 
 
  Recently Added Patents
Hydraulic system for double stacker industrial truck
Transistor array for testing
MOS transistor structure with in-situ doped source and drain and method for forming the same
Communications module apparatus, integrated circuit and method of communicating data
Continuous carbon-nanotube-reinforced polymer precursors and carbon fibers
Ceramic compositions for improved extrusion
FGF21 mutant fusion polypeptides and uses thereof
  Randomly Featured Patents
Growth factor isoform
Vacuum suction type urinating aid
Fuel cell systems with maintenance hydration by displacement of primary power
Pressure sensing apparatus
Cache result register for quick cache information lookup
Diffuser in an air mass flow controller
Display driver
Drum top drier
Transimpedance amplifier with integrated filtering and reduced parasitic capacitance
Tent liners/walls for cold weather operations